CLINICAL_TRIALS
trial_result
· 2012-11-12
Clinical Trial Update: Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy [Phase 2]
Summary
A Phase 2 study evaluating Centella Asiatica Selected Triterpenes (CAST) for diabetic neuropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oregon Health and Science University | Conditions: Diabetic Neuropathy | Phase 2 | Status: COMPLETED